{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:58:12Z","timestamp":1649030292759},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00430-019-00650-5","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T18:02:34Z","timestamp":1575655354000},"page":"125-137","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Functional characterization and evaluation of protective efficacy of EA752\u2013862 monoclonal antibody against B. anthracis vegetative cell and spores"],"prefix":"10.1007","volume":"209","author":[{"given":"Saugata","family":"Majumder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreya","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Shivakiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. V.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas Kumar","family":"Somani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,6]]},"reference":[{"key":"650_CR1","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/toxins3081004","volume":"8","author":"Z Chen","year":"2011","unstructured":"Chen Z, Mahtab M, Robert P (2011) Monoclonal antibody therapies against anthrax. Toxins 8:1004\u20131019. https:\/\/doi.org\/10.3390\/toxins3081004","journal-title":"Toxins"},{"issue":"6","key":"650_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.mam.2009.08.007","volume":"30","author":"G Van der Goot","year":"2009","unstructured":"Van der Goot G, Young JA (2009) Receptors of anthrax toxin and cell entry. Mol Aspects Med 30(6):406\u2013412. https:\/\/doi.org\/10.1016\/j.mam.2009.08.007","journal-title":"Mol Aspects Med"},{"issue":"2","key":"650_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.annemergmed.2005.11.035","volume":"48","author":"JE Holty","year":"2006","unstructured":"Holty JE, Kim RY, Bravata DM (2006) Anthrax: a systematic review of atypical presentations. Ann Emerg Med 48(2):200\u2013211. https:\/\/doi.org\/10.1016\/j.annemergmed.2005.11.035","journal-title":"Ann Emerg Med"},{"key":"650_CR4","doi-asserted-by":"publisher","DOI":"10.3201\/eid1404.070969","author":"EJ Stern","year":"2008","unstructured":"Stern EJ, Uhde KB, Shadomy SV, Messonnier N (2008) Conference report on public health and clinical guidelines for anthrax. Emerg Infect Dis. https:\/\/doi.org\/10.3201\/eid1404.070969","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"650_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/17460913.4.1.35","volume":"4","author":"A Schneemann","year":"2009","unstructured":"Schneemann A, Manchester M (2009) Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax. Future Microbiol 4(1):35\u201343. https:\/\/doi.org\/10.2217\/17460913.4.1.35","journal-title":"Future Microbiol"},{"key":"650_CR6","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01590-17","author":"LN Henning","year":"2018","unstructured":"Henning LN, Carpenter S, Stark GV, Serbina NV (2018) Development of protective immunity in New Zealand white rabbits challenged with Bacillus anthracis spores and treated with antibiotics and obiltoxaximab, a monoclonal antibody against protective antigen. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/aac.01590-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"3\u20134","key":"650_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","volume":"22","author":"SF Little","year":"2004","unstructured":"Little SF, Ivins BE, Fellows PF, Pitt ML, Norris SL, Andrews GP (2004) Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine. Vaccine 22(3\u20134):422\u2013430. https:\/\/doi.org\/10.1016\/j.vaccine.2003.07.004","journal-title":"Vaccine"},{"issue":"2","key":"650_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1128\/IAI.70.2.544-550.2002","volume":"70","author":"D Kobiler","year":"2002","unstructured":"Kobiler D, Gozes Y, Rosenberg H, Marcus D, Reuveny S, Altboum Z (2002) Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization. Infect Immun 70(2):544\u2013550. https:\/\/doi.org\/10.1128\/IAI.70.2.544-550.2002","journal-title":"Infect Immun"},{"issue":"31","key":"650_CR9","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1016\/S0264-410X(01)00197-9","volume":"19","author":"RJ Beedham","year":"2001","unstructured":"Beedham RJ, Turnbull PC, Williamson ED (2001) Passive transfer of protection against Bacillus anthracis infection in a murine model. Vaccine 19(31):4409\u20134416. https:\/\/doi.org\/10.1016\/S0264-410X(01)00197-9","journal-title":"Vaccine"},{"issue":"32","key":"650_CR10","doi-asserted-by":"publisher","first-page":"13487","DOI":"10.1073\/pnas.0906581106","volume":"106","author":"Z Chen","year":"2009","unstructured":"Chen Z, Moayeri M, Zhao H, Crown D, Leppla SH, Purcell RH (2009) Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding. Proc Natl Acad Sci USA 106(32):13487\u201313492. https:\/\/doi.org\/10.1073\/pnas.0906581106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"650_CR11","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1128\/IAI.00529-07","volume":"75","author":"HF Staats","year":"2007","unstructured":"Staats HF, Alam SM, Scearce RM, Kirwan SM, Zhang JX, Gwinn WM, Haynes BF (2007) In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity. Infect Immun 75(11):5443\u20135452. https:\/\/doi.org\/10.1128\/IAI.00529-07","journal-title":"Infect Immun"},{"issue":"14","key":"650_CR12","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1073\/pnas.0401351101","volume":"101","author":"TR Kozel","year":"2004","unstructured":"Kozel TR, Murphy WJ, Brandt S, Blazar BR, Lovchik JA, Thorkildson P, Percival A, Lyons CR (2004) Monoclonal antibodies to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proc Natl Acad Sci USA 101(14):5042\u20135047. https:\/\/doi.org\/10.1073\/pnas.0401351101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"650_CR13","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1128\/JB.184.23.6448-6456.2002","volume":"184","author":"E Couture-Tosi","year":"2002","unstructured":"Couture-Tosi E, Delacroix H, Mignot T, Mesnage S, Chami M, Fouet A, Mosser G (2002) Structural analysis and evidence for dynamic emergence of Bacillus anthracis S-layer networks. J Bacteriol 184(23):6448\u20136456. https:\/\/doi.org\/10.1128\/JB.184.23.6448-6456.2002","journal-title":"J Bacteriol"},{"issue":"3","key":"650_CR14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1046\/j.1365-2958.1999.01232.x","volume":"31","author":"S Mesnage","year":"1999","unstructured":"Mesnage S, Tosi-Couture E, Fouet A (1999) Production and cell surface anchoring of functional fusions between the SLH motifs of the Bacillus anthracis S-layer proteins and the Bacillus subtilis levansucrase. Mol Microbiol 31(3):927\u2013936. https:\/\/doi.org\/10.1046\/j.1365-2958.1999.01232.x","journal-title":"Mol Microbiol"},{"issue":"17","key":"650_CR15","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1093\/emboj\/19.17.4473","volume":"19","author":"S Mesnage","year":"2000","unstructured":"Mesnage S, Fontaine T, Mignot T, Delepierre M, Mock M, Fouet A (2000) Bacterial SLH domain proteins are non-covalently anchored to the cell surface via a conserved mechanism involving wall polysaccharide pyruvylation. EMBO J 19(17):4473\u20134484. https:\/\/doi.org\/10.1093\/emboj\/19.17.4473","journal-title":"EMBO J"},{"issue":"6","key":"650_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.mam.2009.07.00","volume":"30","author":"A Fouet","year":"2009","unstructured":"Fouet A (2009) The surface of Bacillus anthracis. Mol Aspects Med 30(6):374\u2013385. https:\/\/doi.org\/10.1016\/j.mam.2009.07.00","journal-title":"Mol Aspects Med"},{"issue":"1","key":"650_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nm0198-088","volume":"4","author":"P Dullforce","year":"1998","unstructured":"Dullforce P, Sutton DC, Heath AW (1998) Enhancement of T cell-independent immune responses in vivo by CD40 antibodies. Nat Med 4(1):88\u201391","journal-title":"Nat Med"},{"issue":"5","key":"650_CR18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.vaccine.2007.11.072","volume":"26","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Qiu J, Zhou Y, Farhangfar F, Hester J, Lin AY, Decker WK (2008) Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses. Vaccine. 26(5):614\u2013622. https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.072","journal-title":"Vaccine."},{"issue":"2","key":"650_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bbrc.2012.04.007","volume":"421","author":"M Uchida","year":"2012","unstructured":"Uchida M, Harada T, Enkhtuya J, Kusumoto A, Kobayashi Y, Chiba S, Shyaka A, Kawamoto K (2012) Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice. Biochem Biophys Res Commun 421(2):323\u2013328. https:\/\/doi.org\/10.1016\/j.bbrc.2012.04.007","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"650_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molimm.2014.01.012","volume":"59","author":"SS Makam","year":"2014","unstructured":"Makam SS, Kingston JJ, Harischandra MS, Batra HV (2014) Protective antigen and extractable antigen 1 based chimeric protein confers protection against Bacillus anthracis in mouse model. Mol Immunol 59(1):91\u201399. https:\/\/doi.org\/10.1016\/j.molimm.2014.01.012","journal-title":"Mol Immunol"},{"issue":"2","key":"650_CR21","doi-asserted-by":"publisher","first-page":"208IN1-218","DOI":"10.1016\/S0022-2836(61)80047-8","volume":"3","author":"J Marmur","year":"1961","unstructured":"Marmur J (1961) A procedure for the isolation of deoxyribonucleic acid from micro-organisms. J Mol Biol 3(2):208IN1-218","journal-title":"J Mol Biol"},{"key":"650_CR22","first-page":"274","volume":"4","author":"MS Shivakiran","year":"2013","unstructured":"Shivakiran MS, Kingston JJ, Uppalapati S, Radhika M, Tuteja U, Murali HS, Batra HV (2013) Application of extractable antigen 1 (EA1) for specific detection of Bacillus anthracis cells. Int J Pharm Bio Sci 4:274\u2013283","journal-title":"Int J Pharm Bio Sci"},{"issue":"5517","key":"650_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G K\u00f6hler","year":"1975","unstructured":"K\u00f6hler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256(5517):495\u2013497","journal-title":"Nature"},{"key":"650_CR24","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard. Clinical and Laboratory Standards Institute document M7-A7 [ISBN 1-56238-587-9]","author":"NCCLS","year":"2006","unstructured":"NCCLS (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard. Clinical and Laboratory Standards Institute document M7-A7 [ISBN 1-56238-587-9]. Clinical and Laboratory Standards Institute, Pennsylvania"},{"issue":"1","key":"650_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijantimicag.2011.09.010","volume":"9","author":"S Kanthawong","year":"2012","unstructured":"Kanthawong S, Bolscher JG, Veerman EC, van Marle J, de Soet HJ, Nazmi K, Wongratanacheewin S, Taweechaisupapong S (2012) Antimicrobial and anti-biofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei. Int J Antimicrob Agents 9(1):39\u201344. https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.09.010","journal-title":"Int J Antimicrob Agents"},{"key":"650_CR26","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","volume":"147","author":"S Welkos","year":"2001","unstructured":"Welkos S, Little S, Friedlander A, Fritz D, Fellows P (2001) The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147:1677\u20131685. https:\/\/doi.org\/10.1099\/00221287-147-6-1677","journal-title":"Microbiology"},{"issue":"2","key":"650_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0022-1759(84)90015-2","volume":"72","author":"H Towbin","year":"1984","unstructured":"Towbin H, Schoenenberger C, Ball R, Braun DG, Rosenfelder G (1984) Glycosphingolipid-blotting: an immunological detection procedure after separation by thin layer chromatography. J Immunol Methods 72(2):471\u2013479","journal-title":"J Immunol Methods"},{"issue":"3","key":"650_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/003335490812300315","volume":"123","author":"MN Mongoh","year":"2008","unstructured":"Mongoh MN, Dyer NW, Stoltenow CL, Khaitsa ML (2008) Risk factors associated with anthrax outbreak in animals in North Dakota, 2005: a retrospective case-control study. Public Health Rep 123(3):352\u2013359. https:\/\/doi.org\/10.1177\/003335490812300315","journal-title":"Public Health Rep"},{"issue":"11","key":"650_CR29","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1128\/AAC.00090-06","volume":"50","author":"LM Kao","year":"2006","unstructured":"Kao LM, Bush K, Barnewall R, Estep J, Thalacker FW, Olson PH, Drusano GL, Minton N, Chien S, Hemeryck A, Kelley MF (2006) Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model. Antimicrob Agents Chemother 50(11):3535\u20133542. https:\/\/doi.org\/10.1128\/AAC.00090-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"650_CR30","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1128\/IAI.00575-07","volume":"75","author":"IJ Glomski","year":"2007","unstructured":"Glomski IJ, Corre JP, Mock M, Goossens PL (2007) Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice. Infect Immun 75(10):4754\u20134761. https:\/\/doi.org\/10.1128\/IAI.00575-07","journal-title":"Infect Immun"},{"issue":"38","key":"650_CR31","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1016\/j.vaccine.2008.07.015","volume":"26","author":"RJ Cybulski Jr","year":"2008","unstructured":"Cybulski RJ Jr, Sanz P, McDaniel D, Darnell S, Bull RL, O\u2019Brien AD (2008) Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen. Vaccine 26(38):4927\u20134939. https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.015","journal-title":"Vaccine"},{"issue":"5","key":"650_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1469-0691.2004.00852.x","volume":"10","author":"E Shlyakhov","year":"2004","unstructured":"Shlyakhov E, Shoenfeld Y, Gilburd B, Rubinstein E (2004) Evaluation of Bacillus anthracis extractable antigen for testing anthrax immunity. Clin Microbiol Infect 10(5):421\u2013424. https:\/\/doi.org\/10.1111\/j.1469-0691.2004.00852.x","journal-title":"Clin Microbiol Infect"},{"issue":"5\u20136","key":"650_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0147-9571(03)00023-7","volume":"26","author":"P Binder","year":"2003","unstructured":"Binder P, Attre O, Boutin JP, Cavallo JD, Debord T, Jouan A, Vidal D (2003) Medical management of biological warfare and bioterrorism: place of the immunoprevention and the immunotherapy. Comp Immunol Microbiol Infect Dis 26(5\u20136):401\u2013421. https:\/\/doi.org\/10.1016\/S0147-9571(03)00023-7","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"6","key":"650_CR34","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1046\/j.1365-2958.1997.2941659.x","volume":"23","author":"S Mesnage","year":"1997","unstructured":"Mesnage S, Tosi-Couture E, Mock M, Gounon P, Fouet A (1997) Molecular characterization of the Bacillus anthracis main S-layer component: evidence that it is the major cell-associated antigen. Mol Microbiol 23(6):1147\u20131155. https:\/\/doi.org\/10.1046\/j.1365-2958.1997.2941659.x","journal-title":"Mol Microbiol"},{"key":"650_CR35","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1099\/mic.0.27832-0","volume":"151","author":"T Candela","year":"2005","unstructured":"Candela T, Mignot T, Hagnerelle X, Haustant M, Fouet A (2005) Genetic analysis of Bacillus anthracis Sap S-layer protein crystallization domain. Microbiology 151:1485\u20131490. https:\/\/doi.org\/10.1099\/mic.0.27832-0","journal-title":"Microbiology"},{"issue":"3","key":"650_CR36","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1128\/JB.02005-12","volume":"195","author":"YT Wang","year":"2013","unstructured":"Wang YT, Oh SY, Hendrickx AP, Lunderberg JM, Schneewind O (2013) Bacillus cereus G9241 S-layer assembly contributes to the pathogenesis of anthrax-like disease in mice. J Bacteriol 195(3):596\u2013605. https:\/\/doi.org\/10.1128\/JB.02005-12","journal-title":"J Bacteriol"},{"key":"650_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-micro-090816-093512","volume":"71","author":"D Missiakas","year":"2017","unstructured":"Missiakas D, Schneewind O (2017) Assembly and function of the Bacillus anthracis S-layer. Annu Rev Microbiol 71:79\u201398. https:\/\/doi.org\/10.1146\/annurev-micro-090816-093512","journal-title":"Annu Rev Microbiol"},{"issue":"1\u20132","key":"650_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1359-6446(05)03638-X","volume":"11","author":"MA Tabrizi","year":"2006","unstructured":"Tabrizi MA, Tseng CM, Roskos LK (2006) Elimination mechanisms of therapeutic monoclonal antibodies. Drug Discov Today 11(1\u20132):81\u201388. https:\/\/doi.org\/10.1016\/S1359-6446(05)03638-X","journal-title":"Drug Discov Today"},{"issue":"4","key":"650_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.micpath.2004.06.013","volume":"37","author":"CK Cote","year":"2004","unstructured":"Cote CK, Rea KM, Norris SL, van Rooijen N, Welkos SL (2004) The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb Pathog 37(4):169\u2013175. https:\/\/doi.org\/10.1016\/j.micpath.2004.06.013","journal-title":"Microb Pathog"},{"issue":"1","key":"650_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micpath.2004.10.001","volume":"38","author":"JA Bozue","year":"2005","unstructured":"Bozue JA, Parthasarathy N, Phillips LR, Cote CK, Fellows PF, Mendelson I, Shafferman A, Friedlander AM (2005) Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs. Microb Pathog 38(1):1\u201312. https:\/\/doi.org\/10.1016\/j.micpath.2004.10.001","journal-title":"Microb Pathog"},{"issue":"11","key":"650_CR41","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1128\/IAI.73.11.7495-7501.2005","volume":"73","author":"TJ Kang","year":"2005","unstructured":"Kang TJ, Matthew JF, Matthew AW, Stephen H, Subhendu B, Les B, Alan SC (2005) Murine macrophages kill the vegetative form of Bacillus anthracis. Infec Immun 73(11):7495\u20137501","journal-title":"Infec Immun"},{"issue":"9","key":"650_CR42","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1128\/AAC.00267-11","volume":"55","author":"SC Welkos","year":"2011","unstructured":"Welkos SC, Cote K, Hahn UO, Shastak J, Jedermann J, Bozue G, Jung P et al (2011) Humanized \u03b8-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infections. Antimicrob Agents Chemoth 55(9):4238\u20134250","journal-title":"Antimicrob Agents Chemoth"},{"issue":"1","key":"650_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2958.1999.01137.x","volume":"31","author":"C Guidi-Rontani","year":"1999","unstructured":"Guidi-Rontani C, Weber-Levy M, Labruyere E, Mock M (1999) Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol 31(1):9\u201317","journal-title":"Mol Microbiol"},{"issue":"7","key":"650_CR44","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1086\/382656","volume":"189","author":"G Ruthel","year":"2004","unstructured":"Ruthel G, Ribot WJ, Bavari S, Hoover TA (2004) Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. J Infect Dis 189(7):1313\u20131316. https:\/\/doi.org\/10.1086\/382656","journal-title":"J Infect Dis"},{"issue":"6","key":"650_CR45","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.mam.2009.06.002","volume":"30","author":"JN Tournier","year":"2009","unstructured":"Tournier JN, Rossi Paccani S, Quesnel-Hellmann A, Baldari CT (2009) Anthrax toxins: a weapon to systematically dismantle the host immune defenses. Mol Aspects Med 30(6):456\u2013466. https:\/\/doi.org\/10.1016\/j.mam.2009.06.002","journal-title":"Mol Aspects Med"},{"issue":"1\u20133","key":"650_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0168-1656(95)00092-5","volume":"44","author":"AV Stepanov","year":"1996","unstructured":"Stepanov AV, Marinin LI, Pomerantsev AP, Staritsin NA (1996) Development of novel vaccines against anthrax in man. J Biotechnol. 44(1\u20133):155\u2013160. https:\/\/doi.org\/10.1016\/0168-1656(95)00092-5","journal-title":"J Biotechnol."},{"key":"650_CR47","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1099\/jmm.0.045393-0","volume":"61","author":"CK Cote","year":"2012","unstructured":"Cote CK, Kaatz L, Reinhardt J, Bozue J, Tobery SA, Bassett AD, Sanz P, Darnell SC, Alem F, O\u2019Brien AD, Welkos SL (2012) Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia. J Med Microbiol 61:1380\u20131392. https:\/\/doi.org\/10.1099\/jmm.0.045393-0","journal-title":"J Med Microbiol"},{"key":"650_CR48","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1099\/mic.0.28788-0","volume":"152","author":"J Enkhtuya","year":"2006","unstructured":"Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino S (2006) Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids. Microbiology 152:3103\u20133110. https:\/\/doi.org\/10.1099\/mic.0.28788-0","journal-title":"Microbiology"},{"issue":"1","key":"650_CR49","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.1038\/s41598-018-25502-9","volume":"8","author":"S Majumder","year":"2018","unstructured":"Majumder S, Das S, Somani V, Makam SS, Joseph KJ, Bhatnagar R (2018) A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis. Sci Rep. 8(1):7242. https:\/\/doi.org\/10.1038\/s41598-018-25502-9","journal-title":"Sci Rep."}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-019-00650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-019-00650-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-019-00650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T00:26:23Z","timestamp":1607127983000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-019-00650-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,6]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1007\/s00430-019-00650-5","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,6]]},"assertion":[{"value":"17 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}